Director Gibson Christopher sold Recursion Pharmaceuticals ($RXRX) shares on the open market 17 times over the past year, totaling $8.1 million. His most recent sale occurred on February 19, 2026. These sales rank 1336th out of 11,678 insiders in our database by value, below the average of $8.6 million per insider but above the typical 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class B Common Stock | 40000 | $0.00 | 5,307,334.0000 | 514,895,802 | 0.75% | 0.01% |
| March 23, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class A Common Stock | 40000 | $0.00 | 946,556.0000 | 514,895,802 | 4.41% | 0.01% |
| March 23, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | S | Class A Common Stock | 40000 | $3.25 | 906,556.0000 | 514,895,802 | 4.23% | 0.01% |
| March 9, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | G | Class A Common Stock | 20000 | $0.00 | 906,556.0000 | 514,895,802 | 2.16% | 0.00% |
| March 9, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class B Common Stock | 20000 | $0.00 | 5,347,334.0000 | 514,895,802 | 0.37% | 0.00% |
| March 9, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class A Common Stock | 20000 | $0.00 | 926,556.0000 | 514,895,802 | 2.21% | 0.00% |
| March 3, 2026 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Gibson Christopher | Director | A | Stock Option (right to buy) | 73087 | $0.00 | 73,087.0000 | 301,907,431 | 9999.99% | 0.02% |
| March 3, 2026 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Gibson Christopher | Director | A | Common Stock | 53913 | $0.00 | 53,913.0000 | 301,907,431 | 9999.99% | 0.02% |
| Feb. 19, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | S | Class A Common Stock | 40000 | $3.46 | 906,556.0000 | 514,895,802 | 4.23% | 0.01% |
| Feb. 19, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class A Common Stock | 40000 | $0.00 | 946,556.0000 | 514,895,802 | 4.41% | 0.01% |
| Feb. 17, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | F | Class A Common Stock | 27265 | $3.49 | 906,556.0000 | 514,895,802 | 2.92% | 0.01% |
| Feb. 19, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class B Common Stock | 40000 | $0.00 | 5,367,334.0000 | 514,895,802 | 0.74% | 0.01% |
| Feb. 4, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class A Common Stock | 40000 | $0.00 | 953,839.0000 | 514,895,802 | 4.38% | 0.01% |
| Feb. 6, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | F | Class A Common Stock | 10364 | $3.56 | 933,821.0000 | 514,895,802 | 1.10% | 0.00% |
| Feb. 6, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | A | Class A Common Stock | 30346 | $0.00 | 944,185.0000 | 514,895,802 | 3.32% | 0.01% |
| Feb. 4, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | S | Class A Common Stock | 40000 | $4.12 | 913,839.0000 | 514,895,802 | 4.19% | 0.01% |
| Feb. 4, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class B Common Stock | 40000 | $0.00 | 5,407,334.0000 | 514,895,802 | 0.73% | 0.01% |
| Jan. 20, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class A Common Stock | 40000 | $0.00 | 953,839.0000 | 514,895,802 | 4.38% | 0.01% |
| Jan. 20, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | S | Class A Common Stock | 40000 | $4.47 | 913,839.0000 | 514,895,802 | 4.19% | 0.01% |
| Jan. 20, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class B Common Stock | 40000 | $0.00 | 5,447,334.0000 | 514,895,802 | 0.73% | 0.01% |
| Jan. 5, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class B Common Stock | 60000 | $0.00 | 5,487,334.0000 | 514,895,802 | 1.08% | 0.01% |
| Jan. 5, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | C | Class A Common Stock | 60000 | $0.00 | 973,839.0000 | 514,895,802 | 6.57% | 0.01% |
| Jan. 5, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | S | Class A Common Stock | 40000 | $4.25 | 933,839.0000 | 514,895,802 | 4.11% | 0.01% |
| Jan. 5, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Director | G | Class A Common Stock | 20000 | $0.00 | 913,839.0000 | 514,895,802 | 2.14% | 0.00% |
| Dec. 19, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $4.50 | 913,839.0000 | 514,895,802 | 4.19% | 0.01% |
| Dec. 19, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 40000 | $0.00 | 953,839.0000 | 514,895,802 | 4.38% | 0.01% |
| Dec. 19, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 40000 | $0.00 | 5,547,334.0000 | 514,895,802 | 0.72% | 0.01% |
| Dec. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 20000 | $0.00 | 913,839.0000 | 514,895,802 | 2.14% | 0.00% |
| Dec. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $4.63 | 933,839.0000 | 514,895,802 | 4.11% | 0.01% |
| Dec. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 60000 | $0.00 | 973,839.0000 | 514,895,802 | 6.57% | 0.01% |
| Dec. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 60000 | $0.00 | 5,587,334.0000 | 514,895,802 | 1.06% | 0.01% |
| Nov. 19, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $4.16 | 913,839.0000 | 514,895,802 | 4.19% | 0.01% |
| Nov. 19, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 40000 | $0.00 | 953,839.0000 | 514,895,802 | 4.38% | 0.01% |
| Nov. 17, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 40390 | $4.14 | 913,839.0000 | 514,895,802 | 4.23% | 0.01% |
| Nov. 19, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 40000 | $0.00 | 5,647,334.0000 | 514,895,802 | 0.70% | 0.01% |
| Nov. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 20000 | $0.00 | 954,229.0000 | 514,895,802 | 2.05% | 0.00% |
| Nov. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $5.21 | 974,229.0000 | 514,895,802 | 3.94% | 0.01% |
| Nov. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 60000 | $0.00 | 5,687,334.0000 | 514,895,802 | 1.04% | 0.01% |
| Nov. 4, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 60000 | $0.00 | 1,014,229.0000 | 514,895,802 | 6.29% | 0.01% |
| Oct. 23, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 100000 | $0.00 | 5,747,334.0000 | 395,072,094 | 1.71% | 0.03% |
| Oct. 23, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 100000 | $5.70 | 954,229.0000 | 395,072,094 | 9.49% | 0.03% |
| Oct. 23, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 100000 | $0.00 | 1,054,229.0000 | 395,072,094 | 10.48% | 0.03% |
| Oct. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 100000 | $6.04 | 974,229.0000 | 395,072,094 | 9.31% | 0.03% |
| Oct. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 120000 | $0.00 | 5,957,034.0000 | 395,072,094 | 1.97% | 0.03% |
| Oct. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 20000 | $0.00 | 954,229.0000 | 395,072,094 | 2.05% | 0.01% |
| Oct. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 120000 | $0.00 | 1,074,229.0000 | 395,072,094 | 12.58% | 0.03% |
| Sept. 25, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 0 | $0.00 | 6,077,034.0000 | 395,072,094 | 0.00% | 0.00% |
| Sept. 25, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 100000 | $4.76 | 954,229.0000 | 395,072,094 | 9.49% | 0.03% |
| Sept. 25, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 100000 | $0.00 | 1,054,229.0000 | 395,072,094 | 10.48% | 0.03% |
| Sept. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 120000 | $0.00 | 1,074,229.0000 | 395,072,094 | 12.58% | 0.03% |
| Sept. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 100000 | $4.71 | 974,229.0000 | 395,072,094 | 9.31% | 0.03% |
| Sept. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 20000 | $0.00 | 954,229.0000 | 395,072,094 | 2.05% | 0.01% |
| Sept. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 120000 | $0.00 | 6,077,034.0000 | 395,072,094 | 1.94% | 0.03% |
| Aug. 26, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 100000 | $0.00 | 6,197,034.0000 | 395,072,094 | 1.59% | 0.03% |
| Aug. 26, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 100000 | $0.00 | 1,054,229.0000 | 395,072,094 | 10.48% | 0.03% |
| Aug. 26, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 100000 | $4.84 | 954,229.0000 | 395,072,094 | 9.49% | 0.03% |
| Aug. 15, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 40390 | $5.64 | 954,229.0000 | 395,072,094 | 4.06% | 0.01% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 100000 | $0.00 | 6,297,034.0000 | 395,072,094 | 1.56% | 0.03% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 423666 | $0.00 | 6,297,034.0000 | 395,072,094 | 6.30% | 0.11% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 17875 | $5.28 | 994,619.0000 | 395,072,094 | 1.77% | 0.00% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 17875 | $0.00 | 1,012,494.0000 | 395,072,094 | 1.80% | 0.00% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 100000 | $5.28 | 994,619.0000 | 395,072,094 | 9.14% | 0.03% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 100000 | $0.00 | 1,094,619.0000 | 395,072,094 | 10.05% | 0.03% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 994,619.0000 | 395,072,094 | 1.00% | 0.00% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 500300 | $5.28 | 1,004,619.0000 | 395,072,094 | 33.24% | 0.13% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 17875 | $0.00 | 6,297,034.0000 | 395,072,094 | 0.28% | 0.00% |
| Aug. 11, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 423666 | $0.00 | 1,504,919.0000 | 395,072,094 | 39.18% | 0.11% |
| May 15, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 36197 | $4.25 | 1,081,253.0000 | 395,072,094 | 3.24% | 0.01% |
| March 27, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 138574 | $6.04 | 1,117,450.0000 | 395,072,094 | 11.03% | 0.04% |
| March 5, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 1,276,024.0000 | 395,072,094 | 1.59% | 0.01% |
| March 5, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.58 | 1,256,024.0000 | 395,072,094 | 1.57% | 0.01% |
| March 6, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,838,575.0000 | 395,072,094 | 0.29% | 0.01% |
| March 5, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,858,575.0000 | 395,072,094 | 0.29% | 0.01% |
| March 6, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.37 | 1,256,024.0000 | 395,072,094 | 1.57% | 0.01% |
| March 6, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 1,276,024.0000 | 395,072,094 | 1.59% | 0.01% |
| Feb. 18, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 17132 | $10.64 | 1,256,024.0000 | 395,072,094 | 1.35% | 0.00% |
| Feb. 5, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 1,293,156.0000 | 395,072,094 | 1.57% | 0.01% |
| Feb. 5, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.68 | 1,273,156.0000 | 395,072,094 | 1.55% | 0.01% |
| Feb. 5, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,898,575.0000 | 395,072,094 | 0.29% | 0.01% |
| Feb. 6, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $8.12 | 1,273,156.0000 | 395,072,094 | 1.55% | 0.01% |
| Feb. 6, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 1,293,156.0000 | 395,072,094 | 1.57% | 0.01% |
| Feb. 6, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,878,575.0000 | 395,072,094 | 0.29% | 0.01% |
| Feb. 3, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Stock Option (Right to Buy) | 1050567 | $0.00 | 2,551,105.0000 | 395,072,094 | 70.01% | 0.27% |
| Feb. 3, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Class A Common Stock | 16809 | $0.00 | 1,278,725.0000 | 395,072,094 | 1.33% | 0.00% |
| Feb. 3, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Class A Common Stock | 525283 | $0.00 | 1,261,916.0000 | 395,072,094 | 71.31% | 0.13% |
| Feb. 3, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 5569 | $7.25 | 1,273,156.0000 | 395,072,094 | 0.44% | 0.00% |
| Jan. 8, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 756,633.0000 | 0 | 2.72% | 0.00% |
| Jan. 8, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.31 | 736,633.0000 | 0 | 2.64% | 0.00% |
| Jan. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 756,633.0000 | 0 | 2.72% | 0.00% |
| Jan. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.05 | 736,633.0000 | 0 | 2.64% | 0.00% |
| Jan. 8, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,938,575.0000 | 0 | 0.29% | 0.00% |
| Jan. 10, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,918,575.0000 | 0 | 0.29% | 0.00% |
| Dec. 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 756,633.0000 | 0 | 2.72% | 0.00% |
| Dec. 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,958,575.0000 | 0 | 0.29% | 0.00% |
| Dec. 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,978,575.0000 | 0 | 0.29% | 0.00% |
| Dec. 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.12 | 736,633.0000 | 0 | 2.64% | 0.00% |
| Dec. 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 756,633.0000 | 0 | 2.72% | 0.00% |
| Dec. 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.16 | 736,633.0000 | 0 | 2.64% | 0.00% |
| Nov. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 26023 | $6.18 | 736,633.0000 | 0 | 3.41% | 0.00% |
| Nov. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 782,656.0000 | 0 | 2.62% | 0.00% |
| Nov. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.35 | 762,656.0000 | 0 | 2.56% | 0.00% |
| Nov. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $7.74 | 762,656.0000 | 0 | 2.56% | 0.00% |
| Nov. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 6,998,575.0000 | 0 | 0.28% | 0.00% |
| Nov. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 782,656.0000 | 0 | 2.62% | 0.00% |
| Nov. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,018,575.0000 | 0 | 0.28% | 0.00% |
| Oct. 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,058,575.0000 | 0 | 0.28% | 0.00% |
| Oct. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 782,656.0000 | 0 | 2.62% | 0.00% |
| Oct. 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.16 | 762,656.0000 | 0 | 2.56% | 0.00% |
| Oct. 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 782,656.0000 | 0 | 2.62% | 0.00% |
| Oct. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,038,575.0000 | 0 | 0.28% | 0.00% |
| Oct. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.08 | 762,656.0000 | 0 | 2.56% | 0.00% |
| Sept. 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 782,656.0000 | 0 | 2.62% | 0.00% |
| Sept. 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 782,656.0000 | 0 | 2.62% | 0.00% |
| Sept. 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.14 | 762,656.0000 | 0 | 2.56% | 0.00% |
| Sept. 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,098,575.0000 | 0 | 0.28% | 0.00% |
| Sept. 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,078,575.0000 | 0 | 0.28% | 0.00% |
| Sept. 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.04 | 762,656.0000 | 0 | 2.56% | 0.00% |
| Aug. 30, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 5000 | $2.48 | 762,656.0000 | 0 | 0.66% | 0.00% |
| Aug. 30, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 2,167,436.0000 | 0 | 0.23% | 0.00% |
| Aug. 29, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 2,172,436.0000 | 0 | 0.23% | 0.00% |
| Aug. 29, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 5000 | $2.48 | 757,656.0000 | 0 | 0.66% | 0.00% |
| Aug. 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 5000 | $2.48 | 752,656.0000 | 0 | 0.67% | 0.00% |
| Aug. 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 2,177,436.0000 | 0 | 0.23% | 0.00% |
| Aug. 27, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 2,182,436.0000 | 0 | 0.23% | 0.00% |
| Aug. 27, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 5000 | $2.48 | 747,656.0000 | 0 | 0.67% | 0.00% |
| Aug. 26, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 5000 | $2.48 | 742,656.0000 | 0 | 0.68% | 0.00% |
| Aug. 26, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 2,187,436.0000 | 0 | 0.23% | 0.00% |
| Aug. 23, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 5000 | $2.48 | 737,656.0000 | 0 | 0.68% | 0.00% |
| Aug. 23, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 2,192,436.0000 | 0 | 0.23% | 0.00% |
| Aug. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 26082 | $6.69 | 732,656.0000 | 0 | 3.44% | 0.00% |
| Aug. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 30000 | $7.10 | 758,738.0000 | 0 | 3.80% | 0.00% |
| Aug. 8, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 778,738.0000 | 0 | 2.64% | 0.00% |
| Aug. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 30000 | $0.00 | 788,738.0000 | 0 | 3.95% | 0.00% |
| Aug. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 30000 | $0.00 | 7,138,575.0000 | 0 | 0.42% | 0.00% |
| Aug. 8, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,118,575.0000 | 0 | 0.28% | 0.00% |
| Aug. 8, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $6.50 | 758,738.0000 | 0 | 2.57% | 0.00% |
| July 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 50000 | $0.00 | 7,168,575.0000 | 0 | 0.69% | 0.00% |
| June 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 100000 | $0.00 | 6,326,700.0000 | 0 | 1.56% | 0.00% |
| June 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 100000 | $0.00 | 908,738.0000 | 0 | 12.36% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 25000 | $0.00 | 758,738.0000 | 0 | 3.19% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 50000 | $0.00 | 808,738.0000 | 0 | 6.59% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 50000 | $7.48 | 758,738.0000 | 0 | 6.18% | 0.00% |
| July 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 50000 | $0.00 | 808,738.0000 | 0 | 6.59% | 0.00% |
| July 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 50000 | $7.47 | 758,738.0000 | 0 | 6.18% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 50000 | $0.00 | 7,218,575.0000 | 0 | 0.69% | 0.00% |
| June 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 25000 | $0.00 | 7,343,575.0000 | 0 | 0.34% | 0.00% |
| June 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 25000 | $0.00 | 833,738.0000 | 0 | 3.09% | 0.00% |
| June 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 25000 | $0.00 | 808,738.0000 | 0 | 3.00% | 0.00% |
| June 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 50000 | $8.42 | 758,738.0000 | 0 | 6.18% | 0.00% |
| June 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 50000 | $9.00 | 708,738.0000 | 0 | 6.59% | 0.00% |
| May 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 26082 | $10.01 | 808,738.0000 | 0 | 3.12% | 0.00% |
| May 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 21296 | $0.00 | 7,368,575.0000 | 0 | 0.29% | 0.00% |
| May 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 25000 | $0.00 | 913,524.0000 | 0 | 2.66% | 0.00% |
| May 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 50000 | $7.73 | 863,524.0000 | 0 | 5.47% | 0.00% |
| May 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 21296 | $0.00 | 856,116.0000 | 0 | 2.55% | 0.00% |
| May 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 28704 | $8.47 | 834,820.0000 | 0 | 3.32% | 0.00% |
| May 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 21296 | $8.47 | 834,820.0000 | 0 | 2.49% | 0.00% |
| April 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 25000 | $0.00 | 941,875.0000 | 0 | 2.59% | 0.00% |
| April 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 25000 | $0.00 | 941,875.0000 | 0 | 2.59% | 0.00% |
| April 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 25000 | $0.00 | 988,524.0000 | 0 | 2.59% | 0.00% |
| April 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 25000 | $0.00 | 1,043,524.0000 | 0 | 2.34% | 0.00% |
| April 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $8.84 | 1,003,524.0000 | 0 | 3.83% | 0.00% |
| April 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $9.02 | 963,524.0000 | 0 | 3.99% | 0.00% |
| April 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 25000 | $8.84 | 963,524.0000 | 0 | 2.53% | 0.00% |
| April 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 25000 | $0.00 | 963,524.0000 | 0 | 2.66% | 0.00% |
| April 4, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 25000 | $9.02 | 963,524.0000 | 0 | 2.53% | 0.00% |
| March 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 25000 | $0.00 | 1,083,524.0000 | 0 | 2.26% | 0.00% |
| March 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $10.10 | 1,043,524.0000 | 0 | 3.69% | 0.00% |
| March 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 25000 | $0.00 | 1,068,524.0000 | 0 | 2.40% | 0.00% |
| March 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 25000 | $10.10 | 1,043,524.0000 | 0 | 2.34% | 0.00% |
| March 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class B Common Stock | 25000 | $0.00 | 991,875.0000 | 0 | 2.46% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 8674 | $11.40 | 1,144,843.0000 | 0 | 0.76% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 1,114,919.0000 | 0 | 0.91% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 1,104,919.0000 | 0 | 0.90% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 1,136,169.0000 | 0 | 2.83% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 36319 | $11.86 | 1,108,524.0000 | 0 | 3.17% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 1,112,524.0000 | 0 | 0.36% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4000 | $11.56 | 1,108,524.0000 | 0 | 0.36% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 1,128,524.0000 | 0 | 1.80% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $11.55 | 1,108,524.0000 | 0 | 1.77% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 1,109,524.0000 | 0 | 0.09% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $11.56 | 1,108,524.0000 | 0 | 0.09% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,798,434.0000 | 0 | 1.71% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 8674 | $0.00 | 1,884,936.0000 | 0 | 0.46% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,478,371.0000 | 0 | 0.13% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,478,371.0000 | 0 | 0.05% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,478,371.0000 | 0 | 0.27% | 0.00% |
| March 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,478,371.0000 | 0 | 0.01% | 0.00% |
| Feb. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 11148 | $12.43 | 1,104,919.0000 | 0 | 1.00% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Class A Common Stock | 333449 | $0.00 | 1,119,300.0000 | 0 | 42.43% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 3233 | $10.09 | 1,116,067.0000 | 0 | 0.29% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Stock Option (Right to Buy) | 666898 | $0.00 | 2,237,360.0000 | 0 | 42.47% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Class A Common Stock | 11148 | $0.00 | 785,851.0000 | 0 | 1.44% | 0.00% |
| Feb. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 822,975.0000 | 0 | 3.95% | 0.00% |
| Feb. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 48272 | $9.22 | 774,703.0000 | 0 | 5.87% | 0.00% |
| Feb. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,570,462.0000 | 0 | 1.95% | 0.00% |
| Feb. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,513,371.0000 | 0 | 0.13% | 0.00% |
| Feb. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 801,725.0000 | 0 | 1.26% | 0.00% |
| Feb. 7, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 791,725.0000 | 0 | 1.25% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4000 | $9.51 | 791,725.0000 | 0 | 0.50% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 811,725.0000 | 0 | 2.53% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $9.51 | 791,725.0000 | 0 | 2.46% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 792,725.0000 | 0 | 0.13% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $9.49 | 791,725.0000 | 0 | 0.13% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,601,712.0000 | 0 | 1.91% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,523,371.0000 | 0 | 0.13% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,523,371.0000 | 0 | 0.05% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,523,371.0000 | 0 | 0.01% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,523,371.0000 | 0 | 0.27% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 801,328.0000 | 0 | 1.26% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 791,328.0000 | 0 | 1.25% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 822,578.0000 | 0 | 3.95% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 30853 | $9.49 | 791,725.0000 | 0 | 3.75% | 0.00% |
| Jan. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 795,725.0000 | 0 | 0.51% | 0.00% |
| Dec. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 851,157.0000 | 0 | 3.81% | 0.00% |
| Dec. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,558,371.0000 | 0 | 0.13% | 0.00% |
| Dec. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,632,962.0000 | 0 | 1.88% | 0.00% |
| Dec. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 59829 | $7.49 | 791,328.0000 | 0 | 7.03% | 0.00% |
| Dec. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 819,907.0000 | 0 | 1.20% | 0.00% |
| Dec. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 829,907.0000 | 0 | 1.22% | 0.00% |
| Nov. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,568,371.0000 | 0 | 0.13% | 0.00% |
| Nov. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 846,820.0000 | 0 | 1.20% | 0.00% |
| Nov. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 836,820.0000 | 0 | 1.18% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 16913 | $7.18 | 819,907.0000 | 0 | 2.02% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 840,820.0000 | 0 | 0.48% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 873,997.0000 | 0 | 3.71% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 37177 | $5.20 | 836,820.0000 | 0 | 4.25% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,578,371.0000 | 0 | 0.01% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,578,371.0000 | 0 | 0.26% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,578,371.0000 | 0 | 0.05% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,664,212.0000 | 0 | 1.84% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $5.14 | 836,820.0000 | 0 | 0.12% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 837,820.0000 | 0 | 0.12% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $5.11 | 836,820.0000 | 0 | 2.33% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 856,820.0000 | 0 | 2.39% | 0.00% |
| Nov. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4000 | $5.14 | 836,820.0000 | 0 | 0.48% | 0.00% |
| Oct. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 852,747.0000 | 0 | 1.19% | 0.00% |
| Oct. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,593,371.0000 | 0 | 0.13% | 0.00% |
| Oct. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 842,747.0000 | 0 | 1.17% | 0.00% |
| Oct. 4, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 59794 | $7.21 | 842,747.0000 | 0 | 6.63% | 0.00% |
| Oct. 4, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,695,462.0000 | 0 | 1.81% | 0.00% |
| Oct. 4, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 902,541.0000 | 0 | 3.59% | 0.00% |
| Sept. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,603,371.0000 | 0 | 0.13% | 0.00% |
| Sept. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 881,291.0000 | 0 | 1.15% | 0.00% |
| Sept. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 871,291.0000 | 0 | 1.13% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,613,371.0000 | 0 | 0.05% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 905,056.0000 | 0 | 3.58% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 33765 | $8.78 | 871,291.0000 | 0 | 3.73% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 875,291.0000 | 0 | 0.46% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4000 | $8.83 | 871,291.0000 | 0 | 0.46% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 891,291.0000 | 0 | 2.30% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $8.83 | 871,291.0000 | 0 | 2.24% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 872,291.0000 | 0 | 0.11% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $8.84 | 871,291.0000 | 0 | 0.11% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,726,712.0000 | 0 | 1.78% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,613,371.0000 | 0 | 0.26% | 0.00% |
| Sept. 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,613,371.0000 | 0 | 0.01% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 16913 | $9.19 | 873,806.0000 | 0 | 1.90% | 0.00% |
| Aug. 9, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,638,371.0000 | 0 | 0.13% | 0.00% |
| Aug. 9, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 890,719.0000 | 0 | 1.11% | 0.00% |
| Aug. 9, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 900,719.0000 | 0 | 1.12% | 0.00% |
| Aug. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 60955 | $13.02 | 894,779.0000 | 0 | 6.38% | 0.00% |
| Aug. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 955,734.0000 | 0 | 3.38% | 0.00% |
| Aug. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,350,286.0000 | 0 | 2.26% | 0.00% |
| Aug. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 8674 | $0.00 | 1,226,712.0000 | 0 | 0.70% | 0.00% |
| Aug. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4060 | $13.36 | 890,719.0000 | 0 | 0.45% | 0.00% |
| Aug. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 8674 | $11.40 | 924,484.0000 | 0 | 0.95% | 0.00% |
| July 20, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 915,810.0000 | 0 | 1.08% | 0.00% |
| July 20, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,648,371.0000 | 0 | 0.13% | 0.00% |
| July 20, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 925,810.0000 | 0 | 1.09% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4693 | $12.41 | 916,360.0000 | 0 | 0.51% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 550 | $14.03 | 915,810.0000 | 0 | 0.06% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 916,810.0000 | 0 | 0.11% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 236 | $10.87 | 916,574.0000 | 0 | 0.03% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 947,628.0000 | 0 | 3.41% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 127 | $12.36 | 915,886.0000 | 0 | 0.01% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 63 | $13.75 | 915,823.0000 | 0 | 0.01% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 13 | $14.85 | 915,810.0000 | 0 | 0.00% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,797,886.0000 | 0 | 1.71% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,658,371.0000 | 0 | 0.05% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,658,371.0000 | 0 | 0.26% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,658,371.0000 | 0 | 0.01% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 561 | $11.82 | 916,013.0000 | 0 | 0.06% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 3423 | $10.87 | 944,205.0000 | 0 | 0.36% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 7898 | $11.80 | 936,307.0000 | 0 | 0.84% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 3270 | $12.39 | 933,037.0000 | 0 | 0.35% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 17227 | $14.34 | 915,810.0000 | 0 | 1.85% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 919,810.0000 | 0 | 0.44% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 850 | $10.82 | 918,960.0000 | 0 | 0.09% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 2173 | $11.80 | 916,787.0000 | 0 | 0.24% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 850 | $12.41 | 915,937.0000 | 0 | 0.09% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 127 | $14.06 | 915,810.0000 | 0 | 0.01% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 935,810.0000 | 0 | 2.18% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4430 | $10.84 | 931,380.0000 | 0 | 0.47% | 0.00% |
| July 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 10327 | $11.74 | 921,053.0000 | 0 | 1.11% | 0.00% |
| June 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 10000 | $0.00 | 926,378.0000 | 0 | 1.09% | 0.00% |
| June 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 10000 | $0.00 | 7,683,371.0000 | 0 | 0.13% | 0.00% |
| June 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 916,378.0000 | 0 | 1.08% | 0.00% |
| June 7, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 972,814.0000 | 0 | 3.32% | 0.00% |
| June 7, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 56436 | $9.05 | 916,378.0000 | 0 | 5.80% | 0.00% |
| June 7, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,829,136.0000 | 0 | 1.68% | 0.00% |
| May 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 11661 | $5.60 | 941,564.0000 | 0 | 1.22% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 954,225.0000 | 0 | 0.10% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 966,710.0000 | 0 | 0.31% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 963,710.0000 | 0 | 0.31% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 966,710.0000 | 0 | 0.31% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 963,710.0000 | 0 | 0.31% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 966,710.0000 | 0 | 0.31% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 963,710.0000 | 0 | 0.31% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 8662 | $0.00 | 955,048.0000 | 0 | 0.90% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1338 | $0.00 | 956,386.0000 | 0 | 0.14% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 1338 | $0.00 | 955,048.0000 | 0 | 0.14% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 986,298.0000 | 0 | 3.27% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 33073 | $4.71 | 953,225.0000 | 0 | 3.35% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 957,225.0000 | 0 | 0.42% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4000 | $4.91 | 953,225.0000 | 0 | 0.42% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 973,225.0000 | 0 | 2.10% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $4.90 | 953,225.0000 | 0 | 2.06% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $4.92 | 953,225.0000 | 0 | 0.10% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,860,386.0000 | 0 | 1.65% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 7,700,709.0000 | 0 | 0.04% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 7,697,709.0000 | 0 | 0.04% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 7,694,709.0000 | 0 | 0.04% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1338 | $0.00 | 7,693,371.0000 | 0 | 0.02% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,693,371.0000 | 0 | 0.05% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,693,371.0000 | 0 | 0.26% | 0.00% |
| May 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,693,371.0000 | 0 | 0.01% | 0.00% |
| May 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 12000 | $0.00 | 6,641,334.0000 | 0 | 0.18% | 0.00% |
| June 21, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,638,334.0000 | 0 | 0.05% | 0.00% |
| July 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,635,334.0000 | 0 | 0.05% | 0.00% |
| Aug. 17, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,632,334.0000 | 0 | 0.05% | 0.00% |
| Sept. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,629,334.0000 | 0 | 0.05% | 0.00% |
| Oct. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,626,334.0000 | 0 | 0.05% | 0.00% |
| Nov. 16, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,623,334.0000 | 0 | 0.05% | 0.00% |
| Dec. 14, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 6,620,334.0000 | 0 | 0.05% | 0.00% |
| Jan. 5, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 18500 | $0.00 | 6,601,834.0000 | 0 | 0.28% | 0.00% |
| April 25, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 12000 | $0.00 | 594,805.0000 | 0 | 2.06% | 0.00% |
| April 25, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 12000 | $0.00 | 582,805.0000 | 0 | 2.02% | 0.00% |
| May 12, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 12000 | $0.00 | 594,805.0000 | 0 | 2.06% | 0.00% |
| May 12, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 12000 | $0.00 | 582,805.0000 | 0 | 2.02% | 0.00% |
| May 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 12000 | $0.00 | 594,805.0000 | 0 | 2.06% | 0.00% |
| May 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 12000 | $0.00 | 582,805.0000 | 0 | 2.02% | 0.00% |
| June 21, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| June 21, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| July 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| July 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| Aug. 17, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| Aug. 17, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| Sept. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| Sept. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| Oct. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| Oct. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| Nov. 16, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| Nov. 16, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| Dec. 14, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 585,805.0000 | 0 | 0.51% | 0.00% |
| Dec. 14, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 582,805.0000 | 0 | 0.51% | 0.00% |
| Jan. 5, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 18500 | $0.00 | 601,305.0000 | 0 | 3.17% | 0.00% |
| Jan. 5, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 18500 | $7.39 | 582,805.0000 | 0 | 3.08% | 0.00% |
| April 25, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 12000 | $0.00 | 6,665,334.0000 | 0 | 0.18% | 0.00% |
| May 12, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 12000 | $0.00 | 6,653,334.0000 | 0 | 0.18% | 0.00% |
| April 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 928,787.0000 | 0 | 1.07% | 0.00% |
| April 6, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 40000 | $6.64 | 906,710.0000 | 0 | 4.23% | 0.00% |
| April 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 13327 | $6.46 | 946,710.0000 | 0 | 1.39% | 0.00% |
| April 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 31250 | $2.48 | 960,037.0000 | 0 | 3.36% | 0.00% |
| April 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 31250 | $0.00 | 1,891,636.0000 | 0 | 1.63% | 0.00% |
| March 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 938,787.0000 | 0 | 0.32% | 0.00% |
| March 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 3000 | $0.00 | 941,787.0000 | 0 | 0.32% | 0.00% |
| March 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 3000 | $0.00 | 7,785,709.0000 | 0 | 0.04% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 70890 | $8.10 | 963,787.0000 | 0 | 6.85% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Class A Common Stock | 93750 | $2.48 | 1,034,677.0000 | 0 | 9.96% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | M | Stock Option (Right to Buy) | 93750 | $0.00 | 1,922,886.0000 | 0 | 4.65% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $8.09 | 938,787.0000 | 0 | 0.11% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 939,787.0000 | 0 | 0.11% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 20000 | $8.10 | 938,787.0000 | 0 | 2.09% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 20000 | $0.00 | 958,787.0000 | 0 | 2.13% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 4000 | $8.09 | 938,787.0000 | 0 | 0.42% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 4000 | $0.00 | 942,787.0000 | 0 | 0.43% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 10000 | $0.00 | 953,787.0000 | 0 | 1.04% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,788,709.0000 | 0 | 0.01% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 20000 | $0.00 | 7,788,709.0000 | 0 | 0.26% | 0.00% |
| March 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 4000 | $0.00 | 7,788,709.0000 | 0 | 0.05% | 0.00% |
| March 9, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 15000 | $7.77 | 938,787.0000 | 0 | 1.57% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 500 | $0.00 | 7,813,709.0000 | 0 | 0.01% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $7.91 | 940,927.0000 | 0 | 0.11% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 941,927.0000 | 0 | 0.11% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $7.91 | 940,927.0000 | 0 | 0.11% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 941,927.0000 | 0 | 0.11% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 500 | $7.90 | 940,927.0000 | 0 | 0.05% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 500 | $0.00 | 941,427.0000 | 0 | 0.05% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 18500 | $7.92 | 940,927.0000 | 0 | 1.93% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 18500 | $0.00 | 956,427.0000 | 0 | 1.97% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 18500 | $0.00 | 7,813,709.0000 | 0 | 0.24% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,813,709.0000 | 0 | 0.01% | 0.00% |
| March 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,813,709.0000 | 0 | 0.01% | 0.00% |
| Feb. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 1346 | $8.44 | 940,927.0000 | 0 | 0.14% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | F | Class A Common Stock | 1382 | $8.55 | 942,273.0000 | 0 | 0.15% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 18500 | $9.22 | 942,273.0000 | 0 | 1.93% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 500 | $0.00 | 942,773.0000 | 0 | 0.05% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 500 | $9.21 | 942,273.0000 | 0 | 0.05% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 943,273.0000 | 0 | 0.11% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $9.21 | 942,273.0000 | 0 | 0.11% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 943,273.0000 | 0 | 0.11% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $9.20 | 942,273.0000 | 0 | 0.11% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Stock Option (Right to Buy) | 813600 | $0.00 | 2,016,636.0000 | 0 | 67.63% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 18500 | $0.00 | 7,834,709.0000 | 0 | 0.24% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 500 | $0.00 | 7,834,709.0000 | 0 | 0.01% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,834,709.0000 | 0 | 0.01% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,834,709.0000 | 0 | 0.01% | 0.00% |
| Feb. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 18500 | $0.00 | 960,773.0000 | 0 | 1.96% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Class A Common Stock | 11050 | $0.00 | 943,655.0000 | 0 | 1.18% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | A | Class A Common Stock | 406800 | $0.00 | 932,605.0000 | 0 | 77.37% | 0.00% |
| April 25, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 12000 | $0.00 | 570,805.0000 | 0 | 2.06% | 0.00% |
| May 12, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 12000 | $0.00 | 558,805.0000 | 0 | 2.10% | 0.00% |
| May 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 12000 | $0.00 | 546,805.0000 | 0 | 2.15% | 0.00% |
| June 21, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 543,805.0000 | 0 | 0.55% | 0.00% |
| July 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 540,805.0000 | 0 | 0.55% | 0.00% |
| Aug. 17, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 537,805.0000 | 0 | 0.55% | 0.00% |
| Sept. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 534,805.0000 | 0 | 0.56% | 0.00% |
| Oct. 19, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 531,805.0000 | 0 | 0.56% | 0.00% |
| Nov. 16, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 528,805.0000 | 0 | 0.56% | 0.00% |
| Dec. 14, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 525,805.0000 | 0 | 0.57% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 18500 | $0.00 | 544,305.0000 | 0 | 3.52% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 18500 | $7.39 | 525,805.0000 | 0 | 3.40% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 500 | $0.00 | 526,305.0000 | 0 | 0.10% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 500 | $7.38 | 525,805.0000 | 0 | 0.10% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 526,805.0000 | 0 | 0.19% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $7.39 | 525,805.0000 | 0 | 0.19% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class A Common Stock | 1000 | $0.00 | 526,805.0000 | 0 | 0.19% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | S | Class A Common Stock | 1000 | $7.38 | 525,805.0000 | 0 | 0.19% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 18500 | $0.00 | 7,855,709.0000 | 0 | 0.23% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 500 | $0.00 | 7,855,709.0000 | 0 | 0.01% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,855,709.0000 | 0 | 0.01% | 0.00% |
| Jan. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Gibson Christopher | Chief Executive Officer | C | Class B Common Stock | 1000 | $0.00 | 7,855,709.0000 | 0 | 0.01% | 0.00% |